VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS10013889 | HBV | ENSG00000012124.17 | protein_coding | CD22 | No | No | 933 | P20273 Q0EAF5 |
TVIS30082490 | HIV | ENSG00000012124.17 | protein_coding | CD22 | No | No | 933 | P20273 Q0EAF5 |
TVIS20009984 | HPV | ENSG00000012124.17 | protein_coding | CD22 | No | No | 933 | P20273 Q0EAF5 |
TVIS20068354 | HPV | ENSG00000012124.17 | protein_coding | CD22 | No | No | 933 | P20273 Q0EAF5 |
TVIS20016744 | HPV | ENSG00000012124.17 | protein_coding | CD22 | No | No | 933 | P20273 Q0EAF5 |
TVIS44018189 | HTLV-1 | ENSG00000012124.17 | protein_coding | CD22 | No | No | 933 | P20273 Q0EAF5 |
TVIS44033835 | HTLV-1 | ENSG00000012124.17 | protein_coding | CD22 | No | No | 933 | P20273 Q0EAF5 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | CD22 |
---|---|
DrugBank ID | DB04958 |
Drug Name | Epratuzumab |
Target ID | BE0000183 |
UniProt ID | P20273 |
Regulation Type | antibody |
PubMed IDs | 16918261; 17530024; 16814387; 33807678 |
Citations | Steinfeld SD, Youinou P: Epratuzumab (humanised anti-CD22 antibody) in autoimmune diseases. Expert Opin Biol Ther. 2006 Sep;6(9):943-9.@@Leonard JP, Goldenberg DM: Preclinical and clinical evaluation of epratuzumab (anti-CD22 IgG) in B-cell malignancies. Oncogene. 2007 May 28;26(25):3704-13.@@Carnahan J, Stein R, Qu Z, Hess K, Cesano A, Hansen HJ, Goldenberg DM: Epratuzumab, a CD22-targeting recombinant humanized antibody with a different mode of action from rituximab. Mol Immunol. 2007 Feb;44(6):1331-41. Epub 2006 Jun 30.@@Kyriakidis I, Vasileiou E, Rossig C, Roilides E, Groll AH, Tragiannidis A: Invasive Fungal Diseases in Children with Hematological Malignancies Treated with Therapies That Target Cell Surface Antigens: Monoclonal Antibodies, Immune Checkpoint Inhibitors and CAR T-Cell Therapies. J Fungi (Basel). 2021 Mar 5;7(3). pii: jof7030186. doi: 10.3390/jof7030186. |
Groups | Investigational |
Direct Classification | Peptides |
SMILES | |
Pathways | |
PharmGKB | |
ChEMBL |